$bluebird bio (BLUE.US)$bluebird bio Confirms Receipt of an Unsolicited Non-Binding Proposal from Ayrmid SOMERVILLE, Mass.—(BUSINESS WIRE)—March 28, 2025— bluebird bio, Inc. (NASDAQ: BLUE) (“bluebird”) today confirmed it has received an unsolicited non-binding written proposal (the “Ayrmid Proposal”) from Ayrmid Ltd (“Ayrmid”) to acquire bluebird for an upfront cash payment of $4.50 per share and a one-time contingent value right...
3
2
Report
Wanton Boy
:
this is still not confirm right? is biding war?
$Johnson & Johnson (JNJ.US)$Every company has a correct price range. JNJ would be rich if goes above 17 forward P/E, but would be a good risk reward for below 13 p/e for the steady and stable business.$PepsiCo (PEP.US)$is in this category as well.
$Pfizer (PFE.US)$Sold all Haleon shares, Sudden +125M shorts, new weight loss drug results about to be released, and Q1 data nearly ready—everything happened simultaneously, yet no one seems to have a clear explanation. Something BIG coming?
1
4
Report
BC_76
:
it's either they are going to do a BIG ONE ... or .... let's hope it's party time for longists.
Deep Sea
:
By selling all Haleon shares is very positive to its balance sheet. It will add more cash to its cash on hand and strengthen its financial position.
$Johnson & Johnson (JNJ.US)$i find that some days this is a defensive stock, and other days its not. Today I'm betting on it being defensive.
1
Report
韭菜变主力
:
intra-day movement is mainly small time frame trend following, signal to noise ratio is too small. but price range/discovery based on the earnings is a more meaningful signal.
102782319 : nice..